English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  Transdiagnostic subgroups of cognitive impairment in early affective and psychotic illness

Wenzel, J., Badde, L., Haas, S. S., Bonivento, C., Van Rheenen, T. E., Antonucci, L. A., et al. (2023). Transdiagnostic subgroups of cognitive impairment in early affective and psychotic illness. NEUROPSYCHOPHARMACOLOGY. doi:10.1038/s41386-023-01729-7.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Wenzel, Julian, Author
Badde, Luzie, Author
Haas, Shalaila S., Author
Bonivento, Carolina, Author
Van Rheenen, Tamsyn E., Author
Antonucci, Linda A., Author
Ruef, Anne, Author
Penzel, Nora, Author
Rosen, Marlene, Author
Lichtenstein, Theresa, Author
Lalousis, Paris Alexandros, Author
Paolini, Marco, Author
Stainton, Alexandra, Author
Dannlowski, Udo, Author
Romer, Georg, Author
Brambilla, Paolo, Author
Wood, Stephen J., Author
Upthegrove, Rachel, Author
Borgwardt, Stefan, Author
Meisenzahl, Eva, Author
Salokangas, Raimo K. R., AuthorPantelis, Christos, AuthorLencer, Rebekka, AuthorBertolino, Alessandro, AuthorKambeitz, Joseph, AuthorKoutsouleris, Nikolaos1, Author           Dwyer, Dominic B., AuthorKambeitz-Ilankovic, Lana, AuthorPRONIA, Consortium, Author more..
Affiliations:
1Max Planck Fellow Group Precision Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society, ou_3318615              

Content

show
hide
Free keywords: -
 Abstract: Cognitively impaired and spared patient subgroups were identified in psychosis and depression, and in clinical high-risk for psychosis (CHR). Studies suggest differences in underlying brain structural and functional characteristics. It is unclear whether cognitive subgroups are transdiagnostic phenomena in early stages of psychotic and affective disorder which can be validated on the neural level. Patients with recent-onset psychosis (ROP; N = 140; female = 54), recent-onset depression (ROD; N = 130; female = 73), CHR (N = 128; female = 61) and healthy controls (HC; N = 270; female = 165) were recruited through the multi-site study PRONIA. The transdiagnostic sample and individual study groups were clustered into subgroups based on their performance in eight cognitive domains and characterized by gray matter volume (sMRI) and resting-state functional connectivity (rsFC) using support vector machine (SVM) classification. We identified an impaired subgroup (NROP = 79, N-ROD = 30, N-CHR = 37) showing cognitive impairment in executive functioning, working memory, processing speed and verbal learning (all p < 0.001). A spared subgroup (N-ROP = 61, N-ROD = 100, N-CHR = 91) performed comparable to HC. Single-disease subgroups indicated that cognitive impairment is stronger pronounced in impaired ROP compared to impaired ROD and CHR. Subgroups in ROP and ROD showed specific symptom- and functioning-patterns. rsFC showed superior accuracy compared to sMRI in differentiating transdiagnostic subgroups from HC (BAC(impaired) = 58.5%; BAC(spared) = 61.7%, both: p < 0.01). Cognitive findings were validated in the PRONIA replication sample (N = 409). Individual cognitive subgroups in ROP, ROD and CHR are more informative than transdiagnostic subgroups as they map onto individual cognitive impairment and specific functioning- and symptom-patterns which show limited overlap in sMRI and rsFC.

Details

show
hide
Language(s):
 Dates: 2023-09-22
 Publication Status: Published online
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: NEUROPSYCHOPHARMACOLOGY
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: - Sequence Number: - Start / End Page: - Identifier: ISSN: 0893-133X